Tuesday, April 12, 2022
8:30am to 4:30pm (EDT)
Virtually via BlueJeans
PROGRAM BELOW
Please note:
-
Once registered, each registrant will receive a unique URL to join the conference
-
The URL is NOT to be transferred or shared with non-registrants in any way
REGISTRATION NOW CLOSED
Fees:
-
PENN faculty and students: $0
-
Academic, Government, Non-Profit: $60
-
Industry: $85
-
Non-PENN students: $25
MORNING SESSION
David Kent, MD (Tufts University)
Overall Average Treatment Effects and One-Variable-at-a-Time Subgroup Analysis: The Scylla and Charybdis of Evidence Based Medicine
Ellis Unger, MD (Consultant)
An "Unofficial" US Regulatory Perspective
Tom Fleming, PhD (University of Washington)
Exploratory Subgroup Analyses: Why do we Need Particular Caution?
Lisa McShane, PhD (NCI)
Finding the (biomarker-defined) subgroup of patients who benefit from a novel therapy: no time for a game of hide and seek
AFTERNOON SESSION
Noah Simon, PhD (University of Washington)
Adaptive Enrichment Trials: Identifying the 'right' subgroup
Anastasia Ivanova, PhD (UNC)
Methodological Challenges in PrecISE (Precision Interventions for SEvere asthma)
Ilya Lipkovich, PhD (Eli Lilly)
Comparison of Recent Approaches for Subgroup Identification from Clinical and Observational Data
Patrick Schnell, PhD (Ohio State)
Multiplicity Considerations for Analyses of Non-Exchangeable Subgroups
PANELISTS
Mark Rothmann (FDA)
Heterogeneity of Treatment Effects in Clinical Trials
Kosuke Imai (Harvard)
Statistical Inference for Subgroups Discovered by Machine Learning
Kit Roes (European Regulatory Perspective)
Michael Rosenblum (Johns Hopkins)
Janet Wittes (Statistics Collaborative, Inc.)
Evolving Thoughts on Subgroups
- To view or download presentation slide sets, please click on the speaker TOPIC above.
- To view short biographies for each speaker/panelist, please click on their NAME above.
Co-Sponsors
Janine Pritchard
Phone: 215-573-4045 | Email: jpritcha@pennmedicine.upenn.edu